HopeStage
Back to all studies
TerminatedNCT00592852

Fluoxetine for OCD in Children and Adolescents With Bipolarity

Medication studyAges 6–17United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 6 years to 17 years.

What will I do during this study?

The study group receives fluoxetine as a study medication.

Listed locations
CambridgeSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateDecember 2005
Recruitment status
Terminated
Enrollment listed in the registry
13
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 6 Years to 17 Years
Official registry ID
NCT00592852
Official title
Show the full official title

A Pilot Treatment Study of Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder

Recruitment & locations

Terminated

Cambridge

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including fluoxetine.

Who can participate?

Listed age limits: 6 years to 17 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies